Margaret A.WinkerMD, Deputy EditorIndividualAuthorPhil B.FontanarosaMD, Interim CoeditorIndividualAuthor
Copyright 1999 American Medical Association. All Rights Reserved.
Applicable FARS/DFARS Restrictions Apply to Government Use.1999
To the Editor: Mr Holmer1
makes a case in support of direct-to-consumer (DTC) advertising that puts
critics on the defensive. After all, who can be against free speech and educating
and empowering patients?
Holmer plays down the inflationary effect of DTC advertising, with which
the costliest drugs are pitched with all the skill that the advertising budgets
of pharmaceutical companies can buy. There is no corresponding lobby for less
expensive drugs with lower profit potential. Instead, spin doctors take over
from medical doctors and profitability supersedes the presentation of balanced
Alper PR. Direct-to-Consumer Advertising: Education or Anathema?. JAMA. 1999;282(13):1226-1228. doi:10-1001/pubs.JAMA-ISSN-0098-7484-282-13-jbk1006